BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19118524)

  • 1. Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists.
    Zhang S; Liu Q; Wang J; Harnish DC
    Biochem Biophys Res Commun; 2009 Feb; 379(2):476-9. PubMed ID: 19118524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
    FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
    Swales KE; Korbonits M; Carpenter R; Walsh DT; Warner TD; Bishop-Bailey D
    Cancer Res; 2006 Oct; 66(20):10120-6. PubMed ID: 17047076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
    Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes.
    Murakami T; Walczak R; Caron S; Duhem C; Vidal V; Darteil R; Staels B
    Biochem J; 2007 Nov; 407(3):461-9. PubMed ID: 17655523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FXR-mediated regulation of eNOS expression in vascular endothelial cells.
    Li J; Wilson A; Kuruba R; Zhang Q; Gao X; He F; Zhang LM; Pitt BR; Xie W; Li S
    Cardiovasc Res; 2008 Jan; 77(1):169-77. PubMed ID: 18006476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXR, a multipurpose nuclear receptor.
    Lee FY; Lee H; Hubbert ML; Edwards PA; Zhang Y
    Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bile acid receptor FXR is a modulator of intestinal innate immunity.
    Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
    J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
    Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
    Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR-deficiency confers increased susceptibility to torpor.
    Cariou B; Bouchaert E; Abdelkarim M; Dumont J; Caron S; Fruchart JC; Burcelin R; Kuipers F; Staels B
    FEBS Lett; 2007 Nov; 581(27):5191-8. PubMed ID: 17950284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
    Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
    Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient impairment of the adaptive response to fasting in FXR-deficient mice.
    Cariou B; van Harmelen K; Duran-Sandoval D; van Dijk T; Grefhorst A; Bouchaert E; Fruchart JC; Gonzalez FJ; Kuipers F; Staels B
    FEBS Lett; 2005 Aug; 579(19):4076-80. PubMed ID: 16023103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
    Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
    Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.